Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Rimner

Showing results (251-260 of 272) with videos related to

Pageof 28
Sort By:
JCO Precision Oncology|September 4, 2024
Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung CancerYonina R Murciano-Goroff, Angela B-Y Hui, Jose A Araujo Filho, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 29, 2020
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statementMatthias Guckenberger, Claus Belka, Andrea Bezjak, et al.
JTO Clinical and Research Reports|January 2, 2023
A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural MesotheliomaAndreas Rimner, Prasad S Adusumilli, Michael D Offin, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2023
Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation PneumonitisAndreas Rimner, Zachary R Moore, Stephanie Lobaugh, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2020
Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus StatementMatthias Guckenberger, Claus Belka, Andrea Bezjak, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2019
Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning MeetingRitu R Gill, Anne S Tsao, Hedy L Kindler, et al.
The Journal of Clinical Investigation|November 28, 2018
Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injurySahra Bodo, Cécile Campagne, Tin Htwe Thin, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2025
Pulmonary Stereotactic Body Radiation Therapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma: A Multicenter Retrospective StudyFranziska Nägler, Samuel Vorbach, Ahmed Allam Mohamed, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2021
Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66-73]Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusionsSebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Pageof 28

Showing results (251-260 of 272) with videos related to

Sort By:
Pageof 28
JCO Precision Oncology|September 4, 2024
Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung CancerYonina R Murciano-Goroff, Angela B-Y Hui, Jose A Araujo Filho, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 29, 2020
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statementMatthias Guckenberger, Claus Belka, Andrea Bezjak, et al.
JTO Clinical and Research Reports|January 2, 2023
A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural MesotheliomaAndreas Rimner, Prasad S Adusumilli, Michael D Offin, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2023
Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation PneumonitisAndreas Rimner, Zachary R Moore, Stephanie Lobaugh, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2020
Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus StatementMatthias Guckenberger, Claus Belka, Andrea Bezjak, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2019
Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning MeetingRitu R Gill, Anne S Tsao, Hedy L Kindler, et al.
The Journal of Clinical Investigation|November 28, 2018
Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injurySahra Bodo, Cécile Campagne, Tin Htwe Thin, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2025
Pulmonary Stereotactic Body Radiation Therapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma: A Multicenter Retrospective StudyFranziska Nägler, Samuel Vorbach, Ahmed Allam Mohamed, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2021
Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66-73]Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusionsSebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Pageof 28